Dentists in Mountain Top, PA Accepting Medicare
5 Dentists found. Showing 1 - 5
 Dr. Annika Kristin Wessel, DMD Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 20 N Mountain Blvd, Mountain Top, PA 18707 Phone: 570-474-0420 |
 Dr. James Joseph Johns Dds Jr., DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 151 South Mountain Blvd, Mountain Top, PA 18707 Phone: 570-474-2280 Fax: 570-403-5004 |
Dr. Lawrence Alan Sherry, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 20 S Mountain Blvd, Mountain Top, PA 18707 Phone: 570-474-6415 |
Dr. Raphael Anthony Delgiorno, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 27 N Mountain Blvd, Mountain Top, PA 18707 Phone: 570-474-5923 |
Lisa M Dean, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 117 S Main Rd, Mountain Top, PA 18707 Phone: 570-474-9960 |
News Archive
Emergent BioSolutions provides update on TRU-016 Phase 1b study
Emergent BioSolutions Inc. today announced its decision to expand the protocol for its ongoing Phase 1b, single arm, open label study (Protocol 16009) evaluating the safety and efficacy of TRU-016 in combination with rituximab in previously untreated patients with chronic lymphocytic leukemia.
Possible therapeutic target for Duchenne muscular dystrophy
In the April 1st issue of Genes & Development, Dr. Bruce Spiegelman (Dana Farber Cancer Institute) and colleagues identify a key genetic component of and possible therapeutic target for Duchenne muscular dystrophy.
EpiCept, FDA reach agreement on regulatory path forward for Ceplene
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
Platelet receptor could help with diseases that impact RBCs
A receptor found on blood platelets whose importance as a potential pharmaceutical target has long been questioned may in fact be fruitful in drug testing, according to new research from Michigan State University chemists.
› Verified 5 days ago
Pharmacists
Counselors
Occupational Therapists
Clinical Social Workers
Dentists